{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:16:57Z","timestamp":1790018217683,"version":"4.0.1"},"reference-count":127,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.biopsych.2016.02.001","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T18:19:24Z","timestamp":1454609964000},"page":"539-548","source":"Crossref","is-referenced-by-count":139,"title":["Synthetic Cannabinoids\u2014Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis"],"prefix":"10.1016","volume":"79","author":[{"given":"Liana","family":"Fattore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2016.02.001_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fnbeh.2011.00060","article-title":"Beyond THC: The new generation of cannabinoid designer drugs","volume":"5","author":"Fattore","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.biopsych.2016.02.001_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/hup.2410","article-title":"Psyclones: A roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products","volume":"30","author":"Santacroce","year":"2015","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib4","series-title":"Understanding the \u201cSpice\u201d Phenomenon","year":"2009"},{"key":"10.1016\/j.biopsych.2016.02.001_bib5","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1177\/0960327111421945","article-title":"Synthetic cannabinoid and marijuana exposures reported to poison centers","volume":"31","author":"Forrester","year":"2012","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1465-3362.2012.00519.x","article-title":"Patterns of synthetic cannabinoid use in Australia","volume":"32","author":"Barratt","year":"2013","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.biopsych.2016.02.001_bib7","first-page":"16","article-title":"College students and use of K2: An emerging drug of abuse in young persons","volume":"6","author":"Hu","year":"2011"},{"key":"10.1016\/j.biopsych.2016.02.001_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.annemergmed.2012.03.007","article-title":"A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010","volume":"60","author":"Hoyte","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.drugalcdep.2011.07.011","article-title":"A survey study to characterize use of Spice products (synthetic cannabinoids)","volume":"120","author":"Vandrey","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2016.02.001_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/08897077.2013.846288","article-title":"A survey of synthetic cannabinoid consumption by current cannabis users","volume":"35","author":"Gunderson","year":"2014","journal-title":"Subst Abus"},{"key":"10.1016\/j.biopsych.2016.02.001_bib12","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jms.1558","article-title":"\u201cSpice\u201d and other herbal blends: Harmless incense or cannabinoid designer drugs?","volume":"44","author":"Auw\u00e4rter","year":"2009","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.biopsych.2016.02.001_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11419-010-0100-3","article-title":"Identification and quantitative analyses of two cannabimimetic phenylacetylindoles, JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles, JWH-081, JWH-015, JWH-200 and JWH-073, as designer drugs in illegal products","volume":"29","author":"Uchiyama","year":"2011","journal-title":"Forensic Toxicol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib14","first-page":"5042","article-title":"Schedules of controlled substances: Temporary placement of three synthetic cannabinoids into schedule I. Final order","volume":"80","year":"2015","journal-title":"Fed Regist"},{"key":"10.1016\/j.biopsych.2016.02.001_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/15563650.2014.898771","article-title":"The European Emergencies Drug Network (Euro-DEN)","volume":"52","author":"Wood","year":"2014","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib17","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jchromb.2010.03.016","article-title":"Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography\u2013tandem mass spectrometry","volume":"878","author":"Teske","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.biopsych.2016.02.001_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jms.2036","article-title":"Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS","volume":"47","author":"Gottardo","year":"2012","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.biopsych.2016.02.001_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/dta.1663","article-title":"Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry","volume":"7","author":"Holm","year":"2015","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.biopsych.2016.02.001_bib20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/FTD.0000000000000201","article-title":"Validation of an ELISA synthetic cannabinoids urine assay","volume":"37","author":"Barnes","year":"2015","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.biopsych.2016.02.001_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/dta.1667","article-title":"Qualitative analysis of seized synthetic cannabinoids and synthetic cathinones by gas chromatography triple quadrupole tandem mass spectrometry","volume":"7","author":"Gwak","year":"2015","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.biopsych.2016.02.001_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/syn.20277","article-title":"Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125\/131I]AM2233","volume":"60","author":"Dhawan","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2016.02.001_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.115.225326","article-title":"AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and potency of novel synthetic cannabinoids in producing \u03949-tetrahydrocannabinol-like effects in mice","volume":"354","author":"Wiley","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2016.02.001_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2014.06.023","article-title":"JWH-018 in rhesus monkeys: Differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects","volume":"740","author":"Rodriguez","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1056\/NEJMc1313655","article-title":"An outbreak of exposure to a novel synthetic cannabinoid","volume":"370","author":"Monte","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2215\/CJN.05690612","article-title":"AKI associated with synthetic cannabinoids: A case series","volume":"8","author":"Bhanushali","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib27","unstructured":"Makriyannis A, Deng H (2001): Cannabimimetic indole derivatives. US Patent 2005\/0119234 A1, assignee University of Connecticut."},{"key":"10.1016\/j.biopsych.2016.02.001_bib28","doi-asserted-by":"crossref","first-page":"e21917","DOI":"10.1371\/journal.pone.0021917","article-title":"Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity","volume":"6","author":"Brents","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2016.02.001_bib29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1124\/jpet.112.196444","article-title":"Apparent inverse relationship between cannabinoid agonist efficacy and tolerance\/cross-tolerance produced by \u03949-tetrahydrocannabinol treatment in rhesus monkeys","volume":"342","author":"Hruba","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2016.02.001_bib30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/FBP.0b013e328349fbd5","article-title":"Cannabinergic aminoalkylindoles, including AM678=JWH018 found in \u2018Spice,\u2019 examined using drug (\u0394(9)-tetrahydrocannabinol) discrimination for rats","volume":"22","author":"J\u00e4rbe","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib31","article-title":"Delta-9-Tetrahydrocannabinol discriminative stimulus effects of AM2201 and related aminoalkylindole analogs in rats [published online ahead of print Sep 21]","author":"J\u00e4rbe","year":"2015","journal-title":"Behav Pharmacol."},{"key":"10.1016\/j.biopsych.2016.02.001_bib32","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2174\/0929867054020864","article-title":"Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes","volume":"12","author":"Huffman","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.biopsych.2016.02.001_bib33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2174\/138955708783955935","article-title":"Indoles and related compounds as cannabinoid ligands","volume":"8","author":"Manera","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.biopsych.2016.02.001_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2016.02.001_bib35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bjp.0704829","article-title":"Direct inhibition by cannabinoids of human 5-HT3A receptors: Probable involvement of an allosteric modulatory site","volume":"137","author":"Barann","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neuroscience.2010.04.005","article-title":"Cannabinoid administration increases 5HT1A receptor binding and mRNA expression in the hippocampus of adult but not adolescent rats","volume":"169","author":"Zavitsanou","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2016.02.001_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1108\/ADD-02-2014-0006","article-title":"\u201cNoids\u201d in a nutshell: Everything you (don\u2019t) want to know about synthetic cannabimimetics","volume":"7","author":"Papanti","year":"2014","journal-title":"Adv Dual Diagn"},{"key":"10.1016\/j.biopsych.2016.02.001_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00210-010-0517-6","article-title":"Inhibition of monoamine oxidase activity by cannabinoids","volume":"381","author":"Fisar","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib39","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000209291","article-title":"Modulation of glycine receptor function by the synthetic cannabinoid HU210","volume":"83","author":"Demir","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopsych.2016.02.001_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1525-1373.2000.22501.x","article-title":"The cannabinoid system and cytokine network","volume":"225","author":"Klein","year":"2000","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib41","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/bph.12607","article-title":"Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice","volume":"171","author":"Zoppi","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuropharm.2015.02.025","article-title":"MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors","volume":"95","author":"Irie","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2016.02.001_bib43","first-page":"559","article-title":"Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22","volume":"38","author":"Behonick","year":"2014"},{"key":"10.1016\/j.biopsych.2016.02.001_bib44","first-page":"120607","article-title":"A unique case of cardiac arrest following K2 abuse","volume":"2014","author":"Ibrahim","year":"2014","journal-title":"Case Rep Cardiol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib45","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12024-015-9669-5","article-title":"Deaths linked to synthetic cannabinoids","volume":"11","author":"Gerostamoulos","year":"2015","journal-title":"Forensic Sci Med Pathol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11419-013-0190-9","article-title":"A fatal case of MAM-2201 poisoning","volume":"31","author":"Saito","year":"2013","journal-title":"Forensic Toxicol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib47","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jat\/bkt068","article-title":"Toxicological findings of synthetic cannabinoids in recreational users","volume":"37","author":"Kronstrand","year":"2013","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jat\/bks086","article-title":"An accidental fatal intoxication with methoxetamine","volume":"37","author":"Wikstr\u00f6m","year":"2013","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib49","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650.2012.746424","article-title":"2011 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 29th Annual Report","volume":"50","author":"Bronstein","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.biopsych.2016.02.001_bib50","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3109\/15563650.2014.987397","article-title":"2013 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 31st Annual Report","volume":"52","author":"Mowry","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.biopsych.2016.02.001_bib51","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/1556-4029.12216","article-title":"K2 toxicity: Fatal case of psychiatric complications following AM2201 exposure","volume":"58","author":"Patton","year":"2013","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.biopsych.2016.02.001_bib52","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1124\/dmd.112.047530","article-title":"Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2\/Spice: Identification of novel cannabinoid receptor ligands","volume":"40","author":"Chimalakonda","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.biopsych.2016.02.001_bib53","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bcp.2012.01.004","article-title":"Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity","volume":"83","author":"Brents","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/03602532.2013.839700","article-title":"The K2\/Spice phenomenon: Emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products","volume":"46","author":"Brents","year":"2014","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.biopsych.2016.02.001_bib55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/dta.1456","article-title":"UR-144 in products sold via the Internet: Identification of related compounds and characterization of pyrolysis products","volume":"5","author":"Kavanagh","year":"2013","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.biopsych.2016.02.001_bib56","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1360-0443.2012.04078.x","article-title":"Acute toxicity due to the confirmed consumption of synthetic cannabinoids: Clinical and laboratory findings","volume":"108","author":"Hermanns-Clausen","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2016.02.001_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","article-title":"Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids","volume":"39","author":"Seely","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2016.02.001_bib58","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.1523\/JNEUROSCI.3223-14.2014","article-title":"Baths salts, spice, and related designer drugs: The science behind the headlines","volume":"34","author":"Baumann","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2016.02.001_bib59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/15563650.2013.770870","article-title":"Synthetic cannabinoid use associated with acute kidney injury","volume":"51","author":"Thornton","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.biopsych.2016.02.001_bib60","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2215\/CJN.05690612","article-title":"AKI associated with synthetic cannabinoids: A case series","volume":"8","author":"Bhanushali","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib61","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/15563650.2014.932365","article-title":"Acute kidney injury associated with smoking synthetic cannabinoid","volume":"52","author":"Buser","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.biopsych.2016.02.001_bib62","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hup.2292","article-title":"The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products","volume":"28","author":"Winstock","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drugpo.2012.12.002","article-title":"Kronic hysteria: Exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harm","volume":"24","author":"Bright","year":"2013","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.biopsych.2016.02.001_bib64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-013-3188-4","article-title":"Spicing things up: Synthetic cannabinoids","volume":"228","author":"Spaderna","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2016.02.001_bib65","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1177\/1941874411417977","article-title":"The secret \u201cspice\u201d: An undetectable toxic cause of seizure","volume":"1","author":"de Havenon","year":"2011","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.biopsych.2016.02.001_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MAJ.0b013e31824cf5c2","article-title":"Spicy seizure","volume":"344","author":"Pant","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.biopsych.2016.02.001_bib67","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/ADM.0b013e3182619004","article-title":"Internet highs\u2014seizures after consumption of synthetic cannabinoids purchased online","volume":"6","author":"Tofighi","year":"2012","journal-title":"J Addict Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/15563650.2014.925562","article-title":"\u201cCrazy Monkey\u201d poisons man and dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid","volume":"52","author":"Gugelmann","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.biopsych.2016.02.001_bib69","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/0960327114550886","article-title":"Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues","volume":"34","author":"Schep","year":"2014","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib70","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3109\/15563650.2011.609822","article-title":"Severe toxicity following synthetic cannabinoid ingestion","volume":"49","author":"Lapoint","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.biopsych.2016.02.001_bib71","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3371\/CSRP.DUDE.031513","article-title":"Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report","volume":"8","author":"Durand","year":"2015","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"10.1016\/j.biopsych.2016.02.001_bib72","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/dta.158","article-title":"Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls","volume":"3","author":"M\u00f6ller","year":"2011","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.biopsych.2016.02.001_bib73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hup.2312","article-title":"\u201cSpiceophrenia\u201d: A systematic overview of \u201cspice\u201d-related psychopathological issues and a case report","volume":"28","author":"Papanti","year":"2013","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib74","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jms.1877","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples","volume":"46","author":"Dresen","year":"2011","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.biopsych.2016.02.001_bib75","first-page":"464","article-title":"Withdrawal phenomena and dependence syndrome after the consumption of \u201cspice gold\u201d","volume":"106","author":"Zimmermann","year":"2009","journal-title":"Dtsch Artzebl Int"},{"key":"10.1016\/j.biopsych.2016.02.001_bib76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/dar.12225","article-title":"Synthetic cannabinoid withdrawal: A new demand on detoxification services","volume":"34","author":"MacFarlane","year":"2015","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.biopsych.2016.02.001_bib77","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ADM.0b013e31828e1881","article-title":"The synthetic cannabinoid withdrawal syndrome","volume":"7","author":"Nacca","year":"2013","journal-title":"J Addict Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib78","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.euroneuro.2013.01.009","article-title":"Effects of acute detoxification of the herbal blend \u2018Spice Gold\u2019 on dopamine D2\/3 receptor availability: A [18F]fallypride PET study","volume":"23","author":"Rominger","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib79","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11920-005-0036-1","article-title":"The marijuana withdrawal syndrome: Diagnosis and treatment","volume":"7","author":"Haney","year":"2005","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.biopsych.2016.02.001_bib80","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s13181-011-0182-2","article-title":"Convulsions associated with the use of a synthetic cannabinoid product","volume":"8","author":"Schneir","year":"2012","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00228-012-1379-2","article-title":"First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201","volume":"69","author":"McQuade","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib82","first-page":"430","article-title":"Suicidal ideation and self-harm following K2 use","volume":"105","author":"Thomas","year":"2012","journal-title":"J Okla State Med Assoc"},{"key":"10.1016\/j.biopsych.2016.02.001_bib83","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.3928\/01477447-20140401-62","article-title":"Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations","volume":"37","author":"Meijer","year":"2014","journal-title":"Orthopedics"},{"key":"10.1016\/j.biopsych.2016.02.001_bib84","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/phar.1522","article-title":"New drugs of abuse","volume":"35","author":"Rech","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.biopsych.2016.02.001_bib85","first-page":"180921","article-title":"Intravenous lipid emulsion therapy for acute synthetic cannabinoid intoxication: Clinical experience in four cases","volume":"2015","author":"Aksel","year":"2015","journal-title":"Case Rep Emerg Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib86","series-title":"The Effects of Drug Abuse on the Human Nervous System","article-title":"Cannabis, cannabinoids, and the association with psychosis","author":"Radhakrishnan","year":"2012"},{"key":"10.1016\/j.biopsych.2016.02.001_bib87","first-page":"115","article-title":"Impact of cannabis use on the development of psychotic disorders","volume":"1","author":"Wilkinson","year":"2014"},{"key":"10.1016\/j.biopsych.2016.02.001_bib88","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/02791072.2007.10399871","article-title":"Cannabis and psychosis: What is the link?","volume":"39","author":"Ben Amar","year":"2007","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.biopsych.2016.02.001_bib89","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drugpo.2009.09.001","article-title":"Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies","volume":"21","author":"McLaren","year":"2010","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.biopsych.2016.02.001_bib90","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/0269881114565142","article-title":"The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects","volume":"29","author":"van Amsterdam","year":"2015","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib91","first-page":"18","article-title":"Hospitalization associated with use of the synthetic cannabinoid K2","volume":"126","author":"Glue","year":"2013","journal-title":"N Z Med J"},{"key":"10.1016\/j.biopsych.2016.02.001_bib92","doi-asserted-by":"crossref","first-page":"e1064","DOI":"10.1542\/peds.2011-1797","article-title":"Clinical presentation of intoxication due to synthetic cannabinoids","volume":"129","author":"Cohen","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.biopsych.2016.02.001_bib93","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.schres.2009.12.001","article-title":"The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes","volume":"118","author":"M\u00fcller","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2016.02.001_bib94","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1360-0443.2010.03119.x","article-title":"Warning: Legal synthetic cannabinoid-receptor agonists such as JWH018 may precipitate psychosis in vulnerable individuals","volume":"105","author":"Every-Palmer","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2016.02.001_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2011.01.012","article-title":"Synthetic cannabinoid JWH-018 and psychosis: An explorative study","volume":"117","author":"Every-Palmer","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2016.02.001_bib96","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.schres.2011.04.022","article-title":"Persistent psychosis following the use of Spice","volume":"130","author":"Van der Veer","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2016.02.001_bib97","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/15504263.2014.929364","article-title":"Use of synthetic cannabinoids in patients with psychotic disorders: Case series","volume":"10","author":"Celofiga","year":"2014","journal-title":"J Dual Diagn"},{"key":"10.1016\/j.biopsych.2016.02.001_bib98","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jemermed.2014.12.038","article-title":"A common source outbreak of severe delirium associated with exposure to the novel synthetic cannabinoid ADB-PINACA","volume":"48","author":"Schwartz","year":"2015","journal-title":"J Emerg Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib99","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1192\/bjp.185.4.298","article-title":"Prevalence and correlates of self-reported psychotic symptoms in the British population","volume":"185","author":"Johns","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2016.02.001_bib100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1037\/pha0000053","article-title":"Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users","volume":"23","author":"Herrmann","year":"2015","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib101","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1176\/appi.ajp.2011.11010176","article-title":"Psychosis associated with synthetic cannabinoid agonists: A case series","volume":"168","author":"Hurst","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2016.02.001_bib102","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jemermed.2010.10.014","article-title":"\u201cSpice\u201d girls: Synthetic cannabinoid intoxication","volume":"40","author":"Schneir","year":"2011","journal-title":"J Emerg Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib103","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.psym.2011.01.004","article-title":"Psychiatric sequelae of Spice, K2, and synthetic cannabinoid receptor agonists","volume":"52","author":"Benford","year":"2011","journal-title":"Psychosomatics"},{"key":"10.1016\/j.biopsych.2016.02.001_bib104","first-page":"38","article-title":"Synthetic marijuana use and development of catatonia in a 17-year-old male","volume":"97","author":"Smith","year":"2014","journal-title":"Minn Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib105","first-page":"19","article-title":"Synthetic cannabinoid and cathinone use among US soldiers","author":"Berry-Cab\u00e1n","year":"2012","journal-title":"US Army Med Dep J"},{"key":"10.1016\/j.biopsych.2016.02.001_bib106","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08897077.2012.677754","article-title":"Synthetic cannabinoid overdose in a 20-year-old male US soldier","volume":"34","author":"Berry-Cab\u00e1n","year":"2013","journal-title":"Subst Abus"},{"key":"10.1016\/j.biopsych.2016.02.001_bib107","first-page":"1002","article-title":"Synthetic cannabinoid and synthetic cocaine use during pregnancy in a soldier","volume":"1","author":"Berry-Cab\u00e1n","year":"2013","journal-title":"J Subst Abuse Alcohol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib108","first-page":"31","article-title":"Acute mental disturbance caused by synthetic cannabinoid: A potential emerging substance of abuse in Hong Kong","volume":"22","author":"Tung","year":"2012","journal-title":"East Asian Arch Psychiatry"},{"key":"10.1016\/j.biopsych.2016.02.001_bib109","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/schbul\/sbt181","article-title":"Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users","volume":"40","author":"Di Forti","year":"2014","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2016.02.001_bib110","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1192\/bjp.bp.109.064220","article-title":"High-potency cannabis and the risk of psychosis","volume":"195","author":"Di Forti","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2016.02.001_bib111","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ajem.2010.07.020","article-title":"Bad Mojo: Use of the new marijuana substitute leads to more and more ED visits for acute psychosis","volume":"29","author":"Rodgman","year":"2011","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib112","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PEC.0b013e3181e4f416","article-title":"A teenager with agitation: Higher than she should have climbed","volume":"26","author":"Vearrier","year":"2010","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.biopsych.2016.02.001_bib113","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1521-0391.2012.00222.x","article-title":"Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient","volume":"21","author":"Peglow","year":"2012","journal-title":"Am J Addict"},{"key":"10.1016\/j.biopsych.2016.02.001_bib114","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jadohealth.2011.08.002","article-title":"Synthetic cannabinoid use: A case series of adolescents","volume":"49","author":"Castellanos","year":"2011","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.biopsych.2016.02.001_bib115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","article-title":"Spice drugs as a new trend: Mode of action, identification and legislation","volume":"197","author":"Vardakou","year":"2010","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.biopsych.2016.02.001_bib116","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1476-5381.2009.00582.x","article-title":"JWH018, a common constituent of \u201cSpice\u201d herbal blends, is a potent and efficacious cannabinoid CB receptor agonist","volume":"160","author":"Atwood","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib117","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jemermed.2012.07.061","article-title":"Synthetic cannabinoid intoxication: A case series and review","volume":"44","author":"Harris","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.biopsych.2016.02.001_bib118","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20174","article-title":"Novel psychoactive substances of interest for psychiatry","volume":"14","author":"Schifano","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.biopsych.2016.02.001_bib119","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/15563650.2011.584316","article-title":"Three cases of \u201cspice\u201d exposure","volume":"49","author":"Simmons","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.biopsych.2016.02.001_bib120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3928\/02793695-20120703-04","article-title":"Risky recreation: Synthetic cannabinoids have dangerous effects","volume":"50","author":"McGuinness","year":"2012","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/j.biopsych.2016.02.001_bib121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13181-011-0202-2","article-title":"Here today, gone tomorrow \u2026 and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines","volume":"8","author":"Rosenbaum","year":"2012","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib122","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1521-0391.2012.00220.x","article-title":"Case report: Adverse reaction to synthetic marijuana","volume":"21","author":"Faircloth","year":"2012","journal-title":"Am J Addict"},{"key":"10.1016\/j.biopsych.2016.02.001_bib123","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.forsciint.2010.04.003","article-title":"Detection of JWH-018 metabolites in smoking mixture post-administration urine","volume":"200","author":"Sobolevsky","year":"2010","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.biopsych.2016.02.001_bib124","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00216-010-4171-0","article-title":"In vitro phase I metabolism of the synthetic cannabimimetic JWH-018","volume":"398","author":"Wintermeyer","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.biopsych.2016.02.001_bib125","doi-asserted-by":"crossref","first-page":"e21917","DOI":"10.1371\/journal.pone.0021917","article-title":"Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity","volume":"6","author":"Brents","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2016.02.001_bib126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2008.11.081","article-title":"Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment","volume":"1253","author":"Wegener","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2016.02.001_bib127","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2016.02.001_bib128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2016.02.001_bib130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.neuropharm.2015.08.041","article-title":"Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid","volume":"99","author":"De Luca","year":"2015","journal-title":"Neuropharmacology"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322316000834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322316000834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T08:20:58Z","timestamp":1567585258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322316000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":127,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0006322316000834"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2016.02.001","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}